Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
批准号:
7923465
负责人:
Riccardo Dalla-Favera
金额:
$9.99万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-04 至 2013-06-30
关键词:
Academic Medical CentersAppointmentArtsBasic ScienceBehaviorCancer BiologyCancer CenterCancer Center Support GrantCancer Genetics NetworkClinicalClinical ResearchClinical Research AssociateClinical TrialsCommitConnecticutDiagnosisDiseaseEnvironmentEpigenetic ProcessFacultyFundingGoalsHerbert Irving Comprehensive Cancer CenterHospitalsKnowledgeLaboratoriesLaboratory ResearchLeadLeadershipMalignant NeoplasmsMalignant neoplasm of prostateNCI Center for Cancer ResearchNCI-Designated Cancer CenterNew JerseyNew YorkPopulation HeterogeneityPopulation SciencesPresbyterian ChurchPreventionPrevention strategyReportingResearchResearch InfrastructureResource SharingSchoolsSignal TransductionSocial EnvironmentStructureUniversitiesWorkanticancer researchauthoritybasebiomedical informaticscancer epidemiologycancer preventioncancer therapydesigndevelopment of lymphoid malignancyinformatics shared resourceinterdisciplinary collaborationmalignant breast neoplasmmembernovel strategiesprogramssquare foot
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Herbert Irving Comprehensive Cancer Center (HICCC) was designated an NCI Cancer Center in 1972 and gained comprehensive status in 1979. The HICCC is a component of Columbia University Medical Center and associated with New York-Presbyterian Hospital (NYPH). During the period 2003-07, CUMC and NYPH have committed over $312.7 million for i) new research initiatives in basic, clinical and population science; ii) new and expanded facilities for laboratory research and clinical activities; iii) recruitment and program restructuring; iv) support of the Center's administrative office; and v) bridge funding to offset reduced NCI CCSG support.
A new Director, Riccardo Dalla-Favera, MD, was appointed in 2005 and given: i) authority over new facilities, including the Irving Cancer Research Center (ICRC), a new 10-story building dedicated to cancer research, with state-of-the-art laboratories (100,000 square feet) and incremental clinical (30,000 square feet) space in the Herbert Irving Pavilion (HIP); ii) a broad-based recruitment plan, which has already attracted 8 new faculty members to the HICCC; and iii) restructuring and expansion of the shared resources. The Director has fully reshaped the senior leadership of the HICCC with appointments of a Deputy Director for Clinical Research and Associate Directors for Basic Research, Clinical Research, Population Science, Biomedical Informatics, Shared Resources and Administration. The programmatic structure of the HICCC has been reorganized to increase cancer focus and interdisciplinary collaboration, and now includes 216 members from 22 Departments and 6 Schools, assigned to two Basic Research programs (Cancer Signaling Networks and Cancer Genetics & Epigenetics), three Disease-Specific programs (Breast Cancer, Prostate Cancer, and Lymphoid Development & Malignancy), and two Population Science programs (Cancer Epidemiology and Prevention, Control & Disparities). The HICCC administers and supports a total of 12 Shared Resources, of which four have been recently created.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
-
批准号:10737214
-
项目类别:
-
资助金额:$98.7万
-
财政年份:2023
-
负责人:Riccardo Dalla-Favera
-
依托单位:
MSK SPORE in Lymphoma
-
批准号:9753960
-
项目类别:
-
资助金额:$209.4万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:10453790
-
项目类别:
-
资助金额:$94.08万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9528531
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9186876
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9977975
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:10224858
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
-
批准号:9326271
-
项目类别:
-
资助金额:$96.0万
-
财政年份:2016
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of MEF2B mutations in lymphomagenesis
-
批准号:8697703
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2014
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of MEF2B mutations in lymphomagenesis
-
批准号:8849397
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2014
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8539207
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8643783
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
The Role of NOTCH1 in the Pathogenesis of CLL.
-
批准号:8826085
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2013
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8446960
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8627966
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis
-
批准号:8222362
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2012
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Cancer Center Support Grant
-
批准号:7934388
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2009
-
负责人:Riccardo Dalla-Favera
-
依托单位:
Cancer Center Support Grant
-
批准号:7934425
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:Riccardo Dalla-Favera
-
依托单位:
PROGRAM PLANNING AND EVALUATION
-
批准号:7669890
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2008
-
负责人:Riccardo Dalla-Favera
-
依托单位:
PROGRAM LEADERS
-
批准号:7669884
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2008
-
负责人:Riccardo Dalla-Favera
-
依托单位:
海外基金